• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Personalized approach to primary and secondary prevention of ischemic stroke.缺血性中风一级和二级预防的个性化方法。
EPMA J. 2014 Jun 4;5(1):9. doi: 10.1186/1878-5085-5-9. eCollection 2014.
2
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.当代抗血小板和抗凝治疗用于二级卒中预防:当前文献和指南的叙述性综述。
Curr Neurol Neurosci Rep. 2023 May;23(5):235-262. doi: 10.1007/s11910-023-01266-2. Epub 2023 Apr 11.
3
Antiplatelet therapy in secondary ischemic stroke prevention - a short review.二级缺血性脑卒中预防中的抗血小板治疗——简短综述
Rom J Morphol Embryol. 2019;60(2):383-387.
4
Recent clinical trials of antiplatelet therapy in secondary stroke prevention: expectations and results for application in primary care settings.
Am J Med. 2009 Apr;122(4 Suppl 2):S21-31. doi: 10.1016/j.amjmed.2009.02.007.
5
Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome.抗磷脂综合征缺血性脑卒中患者二级预防中单联抗血小板与双联抗血小板抗凝治疗的比较。
Int J Med Sci. 2009 Dec 5;7(1):15-8. doi: 10.7150/ijms.7.15.
6
Preoperative antithrombotic treatment in acutely symptomatic carotid artery stenosis.急性症状性颈动脉狭窄的术前抗血栓治疗。
J Stroke Cerebrovasc Dis. 2022 May;31(5):106396. doi: 10.1016/j.jstrokecerebrovasdis.2022.106396. Epub 2022 Feb 24.
7
Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke.口服抗血小板和抗凝药物在缺血性卒中的预防与管理中的应用
Curr Pharm Des. 2017;23(9):1377-1391. doi: 10.2174/1381612822666161221145614.
8
Oral anticoagulants and non-cardioembolic stroke prevention.
Vasc Med. 2008 Feb;13(1):55-62. doi: 10.1177/1358863X07086191.
9
Antiplatelet therapy in cerebrovascular disorders.脑血管疾病中的抗血小板治疗。
Handb Exp Pharmacol. 2012(210):519-46. doi: 10.1007/978-3-642-29423-5_21.
10
Stroke subtypes and interventional studies for transient ischemic attack.短暂性脑缺血发作的卒中亚型及干预性研究
Front Neurol Neurosci. 2014;33:135-46. doi: 10.1159/000351914. Epub 2013 Oct 11.

引用本文的文献

1
Risks associated with the stroke predisposition at young age: facts and hypotheses in light of individualized predictive and preventive approach.年轻时中风易感性相关风险:基于个体化预测和预防方法的事实与假说
EPMA J. 2019 Feb 20;10(1):81-99. doi: 10.1007/s13167-019-00162-5. eCollection 2019 Mar.
2
Predictive and individualized management of stroke-success story in Czech Republic.捷克共和国中风的预测性和个体化管理——成功案例
EPMA J. 2018 Oct 25;9(4):393-401. doi: 10.1007/s13167-018-0150-x. eCollection 2018 Dec.
3
Distribution of Stroke Risk Factors in Eastern Croatia.克罗地亚东部中风危险因素的分布情况。
Acta Clin Croat. 2018 Mar;57(1):103-109. doi: 10.20471/acc.2018.57.01.12.
4
Pre-graduate and post-graduate education in personalized medicine in the Czech Republic: statistics, analysis and recommendations.捷克共和国个性化医疗的研究生前教育与研究生教育:统计、分析与建议
EPMA J. 2014 Dec 15;5(1):22. doi: 10.1186/1878-5085-5-22. eCollection 2014.
5
Strokes in young adults: epidemiology and prevention.年轻成年人中的中风:流行病学与预防
Vasc Health Risk Manag. 2015 Feb 24;11:157-64. doi: 10.2147/VHRM.S53203. eCollection 2015.

本文引用的文献

1
Prehypertension and the risk of stroke: a meta-analysis.高血压前期与中风风险:一项荟萃分析。
Neurology. 2014 Apr 1;82(13):1153-61. doi: 10.1212/WNL.0000000000000268. Epub 2014 Mar 12.
2
Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association.女性脑卒中预防指南:美国心脏协会/美国卒中协会医疗卫生专业人员的声明。
Stroke. 2014 May;45(5):1545-88. doi: 10.1161/01.str.0000442009.06663.48. Epub 2014 Feb 6.
3
Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry.在 46 个国家的 15400 名急诊患者前瞻性登记研究中,房颤的病因和治疗变化:RE-LY 房颤登记研究。
Circulation. 2014 Apr 15;129(15):1568-76. doi: 10.1161/CIRCULATIONAHA.113.005451. Epub 2014 Jan 24.
4
Edoxaban versus warfarin in patients with atrial fibrillation.依度沙班与华法林用于房颤患者。
N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.
5
Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial.华法林对比阿司匹林用于窦性心律心力衰竭患者的获益:WARCEF 随机对照试验的亚组分析。
Circ Heart Fail. 2013 Sep 1;6(5):988-97. doi: 10.1161/CIRCHEARTFAILURE.113.000372. Epub 2013 Jul 23.
6
2013 ESH/ESC Guidelines for the Management of Arterial Hypertension.2013年欧洲高血压学会/欧洲心脏病学会动脉高血压管理指南
Blood Press. 2013 Aug;22(4):193-278. doi: 10.3109/08037051.2013.812549. Epub 2013 Jun 18.
7
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial.近期腔隙性卒中患者的血压目标:SPS3 随机试验。
Lancet. 2013 Aug 10;382(9891):507-15. doi: 10.1016/S0140-6736(13)60852-1. Epub 2013 May 29.
8
Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis.无症状颈动脉狭窄的管理策略:系统评价和荟萃分析。
Ann Intern Med. 2013 May 7;158(9):676-685. doi: 10.7326/0003-4819-158-9-201305070-00007.
9
Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.卵圆孔未闭封堵与隐源性卒中后药物治疗的比较。
N Engl J Med. 2013 Mar 21;368(12):1092-100. doi: 10.1056/NEJMoa1301440.
10
Percutaneous closure of patent foramen ovale in cryptogenic embolism.经皮卵圆孔未闭封堵术治疗隐源性栓塞。
N Engl J Med. 2013 Mar 21;368(12):1083-91. doi: 10.1056/NEJMoa1211716.

缺血性中风一级和二级预防的个性化方法。

Personalized approach to primary and secondary prevention of ischemic stroke.

作者信息

Polívka Jiří, Rohan Vladimír, Sevčík Petr, Polívka Jiří

机构信息

Department of Neurology, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svodody 80, Pilsen 304 60, Czech Republic ; Department of Neurology, University Hospital Pilsen, Alej Svodody 80, Pilsen 304 60, Czech Republic.

Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University in Prague, Karlovarska 48, Pilsen 301 66, Czech Republic ; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Karlovarska 48, Pilsen 301 66, Czech Republic.

出版信息

EPMA J. 2014 Jun 4;5(1):9. doi: 10.1186/1878-5085-5-9. eCollection 2014.

DOI:10.1186/1878-5085-5-9
PMID:24949113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4063244/
Abstract

Primary and secondary prevention of ischemic stroke represents a significant part of stroke management and health care. Although there are official guidelines concerning stroke management, new knowledge are introduced to them with a slight delay. This article provides an overview of current information on primary and secondary prevention of ischemic stroke. It summarizes information especially in the field of cardioembolic stroke, the use of new anticoagulants and the management of carotid stenosis based on the results of recent clinical studies. The optimal approach in stroke management is to follow these recommendations, to know new strategies and to apply an individual personalized approach in our clinical decisions.

摘要

缺血性中风的一级和二级预防是中风管理和医疗保健的重要组成部分。尽管有关于中风管理的官方指南,但新知识的引入会稍有延迟。本文概述了缺血性中风一级和二级预防的当前信息。它尤其根据近期临床研究结果总结了心源性栓塞性中风领域、新型抗凝剂的使用以及颈动脉狭窄管理方面的信息。中风管理的最佳方法是遵循这些建议,了解新策略,并在我们的临床决策中采用个性化方法。